Morgan Stanley’s NEPHROGENEX INC COM NRX Stock Holding History

Morgan Stanley’s Portfolio NRX Stock Details NRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-23	Closed	–	–	6900
2016 Q1	$0	Sell	23 -1,977	-99%	-$1.64K	﹤0.01%	6905
2015 Q4	$3K	Sell	2,000 -202,969	-99%	-$472K	﹤0.01%	6489
2015 Q3	$693K	Buy	204,969 +25,620	+14%	+$112K	﹤0.01%	4391
2015 Q2	$1.19M	Buy	179,349 +19,364	+12%	+$147K	﹤0.01%	4065
2015 Q1	$1.26M	Sell	159,985 -26,030	-14%	-$204K	﹤0.01%	3953
2014 Q4	$2.48M	Buy	+186,015	New	+$861K	﹤0.01%	3364
2014 Q2	–	Sell	-815	Closed	-$7K	–	6701
2014 Q1	$7K	Buy	+815	New	+$8.3K	﹤0.01%	6199

Morgan Stanley's NRX Position: Q2 2016 in Review

Morgan Stanley sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 23 shares.

Morgan Stanley first reported a position in NRX in Q1 2014 and held it in 7 quarters. The position peaked at $2.48M in Q4 2014. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

Morgan Stanley reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
Morgan Stanley sold 23 NEPHROGENEX INC COM shares in Q2 2016.
Morgan Stanley first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 7 quarters.
Morgan Stanley's NEPHROGENEX INC COM position peaked at $2.48M in Q4 2014.
1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.